Prostaglandin analogs in ophthalmology.

Humans Bimatoprost / therapeutic use Cloprostenol / adverse effects Travoprost / therapeutic use Latanoprost / therapeutic use Prostaglandins F, Synthetic / therapeutic use Ophthalmology Antihypertensive Agents / therapeutic use Amides Prostaglandins, Synthetic / therapeutic use Glaucoma / drug therapy Intraocular Pressure
Antiglaucoma medications bimatoprost latanoprost newer antiglaucoma medications prostaglandin analogs prostaglandins travoprost

Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
05 2023
Historique:
medline: 22 5 2023
pubmed: 19 5 2023
entrez: 19 5 2023
Statut: ppublish

Résumé

Glaucoma is a major cause of irreversible blindness worldwide. Reducing intraocular pressure (IOP) is currently the only approach to prevent further optic nerve head damage. Pharmacotherapy is the mainstay of treatment for glaucoma patients. In recent years, a significant milestone in glaucoma treatment has been a transition to prostaglandin analogs (PGAs) as the first line of drugs. The rapid shift from traditional β-blockers to PGAs is primarily due to their excellent efficacy, convenient once-a-day usage, better diurnal control of IOP, and systemic safety profiles. This review article aims to provide information regarding the various PGAs in practice and also the newer promising drugs.

Identifiants

DOI: 10.4103/IJO.IJO_2706_22 PMID: 37203029 PMC: PMC10391402
pubmed: 37203029
pii: IndianJOphthalmol_2023_71_5_1768_377015
doi: 10.4103/IJO.IJO_2706_22
pmc: PMC10391402
doi:

Substances chimiques

Bimatoprost QXS94885MZ
Cloprostenol 4208238832
Travoprost WJ68R08KX9
Latanoprost 6Z5B6HVF6O
Prostaglandins F, Synthetic 0
Antihypertensive Agents 0
Amides 0
Prostaglandins, Synthetic 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1768-1776

Déclaration de conflit d'intérêts

None

Références

Exp Eye Res. 1989 May;48(5):707-16
pubmed: 2737263
Br J Ophthalmol. 2003 Jan;87(1):57-62
pubmed: 12488264
Ophthalmic Plast Reconstr Surg. 2008 Jul-Aug;24(4):302-7
pubmed: 18645437
Am J Ophthalmol. 2005 Jan;139(1):202-3
pubmed: 15652856
Ophthalmology. 2002 May;109(5):998-1008
pubmed: 11986110
Br J Ophthalmol. 2017 Jun;101(6):796-800
pubmed: 27649982
J Physiol. 1966 Jan;182(1):110-30
pubmed: 4380012
J Ophthalmol. 2018 Sep 27;2018:3190684
pubmed: 30363694
Eur J Ophthalmol. 2012 Jan-Feb;22(1):34-44
pubmed: 22167541
Ophthalmology. 2021 Jan;128(1):P71-P150
pubmed: 34933745
J Glaucoma. 2022 Jun 1;31(6):382-391
pubmed: 35394456
J Glaucoma. 2010 Sep;19(7):460-7
pubmed: 20051890
Invest Ophthalmol Vis Sci. 2013 Jul 16;54(7):4782-90
pubmed: 23766471
J AAPOS. 2017 Oct;21(5):370-374.e1
pubmed: 28887006
Br J Ophthalmol. 2008 Sep;92(9):1227-31
pubmed: 18586898
J Ocul Pharmacol Ther. 2013 May;29(4):382-9
pubmed: 23231442
Adv Prostaglandin Thromboxane Leukot Res. 1995;23:513-8
pubmed: 7732899
Br J Ophthalmol. 2013 Feb;97(2):196-200
pubmed: 23203707
Br J Ophthalmol. 2001 Aug;85(8):983-90
pubmed: 11466259
Br J Ophthalmol. 2021 Jun;105(Suppl 1):1-169
pubmed: 34675001
J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):102-9
pubmed: 24359106
Expert Opin Drug Saf. 2022 Apr;21(4):525-539
pubmed: 34666576
Clin Ophthalmol. 2010 Jul 30;4:741-64
pubmed: 20689791
Am J Ophthalmol. 2003 Jan;135(1):55-63
pubmed: 12504698
Ann Pharmacother. 2014 Dec;48(12):1585-93
pubmed: 25184309
Surv Ophthalmol. 2001 May;45 Suppl 4:S347-51
pubmed: 11434937
Am J Ophthalmol. 2010 Apr;149(4):661-671.e1
pubmed: 20346780
J Ocul Pharmacol Ther. 2022 Apr;38(3):252-260
pubmed: 35230148
J Glaucoma. 2001 Oct;10(5):414-22
pubmed: 11711841
Drugs. 2018 Dec;78(18):1925-1929
pubmed: 30465134
Br J Ophthalmol. 2013 Aug;97(8):989-93
pubmed: 23743437
Curr Eye Res. 2011 Sep;36(9):809-17
pubmed: 21851167
Prog Retin Eye Res. 2001 Sep;20(5):595-624
pubmed: 11470452
Br J Ophthalmol. 2015 Jun;99(6):738-45
pubmed: 25488946
Curr Eye Res. 1998 Jun;17(6):567-72
pubmed: 9663846
Br J Ophthalmol. 2009 Mar;93(3):316-21
pubmed: 19019922
Ophthalmol Glaucoma. 2020 Jan - Feb;3(1):51-59
pubmed: 32672642
Clin Ophthalmol. 2010 Apr 26;4:349-58
pubmed: 20463804
Jpn J Ophthalmol. 2011 Nov;55(6):600-4
pubmed: 21953485
Ophthalmology. 2016 May;123(5):965-73
pubmed: 26875002
Am J Ophthalmol. 2003 May;135(5):688-703
pubmed: 12719078
Graefes Arch Clin Exp Ophthalmol. 1985;222(3):139-41
pubmed: 3856545
Expert Opin Ther Pat. 2019 Oct;29(10):793-803
pubmed: 31462124
Int J Ophthalmol. 2020 Mar 18;13(3):474-480
pubmed: 32309186
Drugs Aging. 1999 May;14(5):387-98
pubmed: 10408738
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Am J Ophthalmol. 2020 Dec;220:53-63
pubmed: 32533949
J Glaucoma. 2019 May;28(5):375-385
pubmed: 30839416
Clin Ophthalmol. 2009;3:471-81
pubmed: 19714225
Turk J Med Sci. 2015;45(4):925-30
pubmed: 26422869
J Ocul Pharmacol Ther. 2003 Dec;19(6):501-15
pubmed: 14733708
Adv Ther. 2020 Apr;37(4):1620-1631
pubmed: 32166538
J Glaucoma. 2016 Mar;25(3):e134-44
pubmed: 25383466
Ophthalmol Ther. 2012 Dec;1(1):5
pubmed: 25135585
Ophthalmology. 2016 Jan;123(1):129-40
pubmed: 26526633
Ophthalmology. 2005 Jul;112(7):1177-85
pubmed: 15921747
Eur J Ophthalmol. 2005 May-Jun;15(3):336-42
pubmed: 15945001
Jpn J Ophthalmol. 2004 Nov-Dec;48(6):602-12
pubmed: 15592791
Hiroshima J Med Sci. 2008 Jun;57(2):69-72
pubmed: 18717189
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S6-12
pubmed: 12204697
Br J Ophthalmol. 2008 Jan;92(1):7-12
pubmed: 18156371
Am J Ophthalmol. 1998 Jul;126(1):37-41
pubmed: 9683147
Ophthalmology. 2011 Oct;118(10):2014-21
pubmed: 21680022

Auteurs

S Subbulakshmi (S)

Department of Glaucoma, Aravind Eye Hospital, Puducherry, India.

Srinivasan Kavitha (S)

Department of Glaucoma, Aravind Eye Hospital, Puducherry, India.

Rengaraj Venkatesh (R)

Department of Glaucoma, Aravind Eye Hospital, Puducherry, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Prostaglandines synthétiques › Prostaglandines F synthétiques › Cloprosténol › Bimatoprost › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Prostaglandines synthétiques › Prostaglandines F synthétiques › Cloprosténol › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Prostaglandines synthétiques › Prostaglandines F synthétiques › Cloprosténol › Travoprost › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Prostaglandines synthétiques › Prostaglandines F synthétiques › Latanoprost › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Prostaglandines synthétiques › Prostaglandines F synthétiques › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Professions de santé › Médecine › Spécialités chirurgicales › Ophtalmologie › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents cardiovasculaires › Antihypertenseurs › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Composés chimiques organiques › Amides › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Prostaglandines synthétiques › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Maladies de l'oeil › Hypertension oculaire › Glaucome › Prostaglandin analogs in ophthalmology.
questionsmedicales.fr › Phénomènes physiologiques oculaires › Pression intraoculaire › Prostaglandin analogs in ophthalmology.